The ascension of Sildenafil initially ignited significant expansion in the pharmaceutical sector, producing a image of guaranteed returns. However, placing capital in companies solely reliant on flagship drugs like the https://mayamtmr581400.blogsuperapp.com/41647764/the-blue-pill-and-pharma-a-risky-play